A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma

Published:2005-07 Issue:6 Volume:41 Page:589-595
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Chua Daniel T.T.,Sham Jonathan S.T.,Au Gordon K.H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference17 articles.

1. Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma;Yeo;Cancer Chemother Pharmacol,1996

2. Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan;Su;Oncology,1993

3. Final report of a Phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type;Azli;Cancer J Sci Am,1995

4. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma;Ma;Cancer,2002

5. Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx;Siu;J Clin Oncol,1998

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study;Radiotherapy and Oncology;2024-07

2. Camrelizumab plus taxanes and cisplatin (TP) chemotherapy or TP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma;2023-04-19

3. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy;Cancer Imaging;2023-02-24

4. Nasopharyngeal Carcinoma in Pediatric and Adolescent Patients;Medical Radiology;2023

5. Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma;Radiation Oncology;2022-07-05